Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C

被引:66
|
作者
Heigle, TJ [1 ]
Stulting, RD [1 ]
Palay, DA [1 ]
机构
[1] EMORY UNIV,DEPT OPHTHALMOL,ATLANTA,GA 30322
关键词
D O I
10.1016/S0002-9394(14)70834-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To study the effect of topical mitomycin C on conjunctival squamous neoplasia. METHODS: Three patients with recurrent conjunctival epithelial neoplasia were treated with topical mitomycin C 0.04-%. RESULTS: Six to 9 months after treatment, no patient had clinical evidence of tumor recurrence. Conjunctival biopsy in two patients and cytology in one patient showed no evidence of tumor 1 to 4 months after treatment. One patient required short-term treatment for corneal edema and epithelial toxicity. CONCLUSION: Topical mitomycin C caused tumor regression without recurrence for 6 to 9 months after treatment.
引用
收藏
页码:397 / 399
页数:3
相关论文
共 50 条
  • [21] Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia
    Daniell, M
    Maini, R
    Tole, D
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 30 (02): : 94 - 98
  • [22] Mitomycin C [MMC] treatment for conjunctival and corneal intraepithelial neoplasia
    Frucht-Pery, J
    Rozenman, Y
    Pe'er, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S649 - S649
  • [23] Long-Term Results of Topical Mitomycin C 0.02% for Primary and Recurrent Conjunctival-Corneal Intraepithelial Neoplasia
    Ballalai, Priscilla L.
    Erwenne, Clelia M.
    Martins, Maria Cristina
    Lowen, Marcia S.
    Barros, Jeison N.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 25 (04): : 296 - 299
  • [24] The Effect of Surgical Wide Excision and Amniotic Membrane Transplantation with Adjuvant Topical Mitomycin C Treatment in Recurrent Conjunctival-Corneal Intraepithelial Neoplasia
    Lee, Jae Hyung
    Kim, Yeong Hoon
    Kim, Man Soo
    Kim, Eun Chul
    SEMINARS IN OPHTHALMOLOGY, 2014, 29 (04) : 192 - 195
  • [25] Conjunctival autograft versus topical mitomycin C in treatment of pterygium
    P S Mahar
    Eye, 1997, 11 : 790 - 792
  • [26] Conjunctival autograft versus topical mitomycin C in treatment of pterygium
    Mahar, PS
    EYE, 1997, 11 (6) : 790 - 792
  • [27] Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia
    Dudney, BW
    Malecha, MA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (05) : 950 - 951
  • [28] Topical mitomycin C for treatment of intraepithelial neoplasia of the ocular surface
    Touriño, R
    Rodríguez-Ares, MT
    Vázquez, JM
    Juárez, A
    Capeans, C
    Sánchez-Salorio, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S336 - S336
  • [29] Topical mitomycin C as a therapy of conjunctival tumours
    Schallenberg, M.
    Niederdraeing, N.
    Steuhl, K. -P.
    Meller, D.
    OPHTHALMOLOGE, 2008, 105 (08): : 777 - 784
  • [30] Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma
    Shields, CL
    Naseripour, M
    Shields, JA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (05) : 601 - 606